Lipids & Metabolic

A new matchstick-sized continuous glucose monitor (CGM) can be implanted under the skin, allowing diabetics to track their blood sugar without the inconvenience of finger pricks and patches, according to a CBS report.

Physician bias against overweight and obese patients is not only prevalent in today’s medical landscape, according to an analysis published in JAMA Feb. 20—it could also be overshadowing quality care and driving some of those patients further from the doctor’s office.

Two U.S. senators launched a bipartisan investigation into rising insulin prices on Feb. 22, sending letters to the drug's top three manufacturers seeking information about why costs have risen so sharply in recent years.

Diabetes mellitus continues to be linked to higher all-cause and CVD mortality in patients living with the disease, according to work published in the Journal of the American Heart Association Feb. 19. But some of that risk could be mitigated by controlling cardiovascular risk factors, and diabetes-related deaths are down overall.

The U.S. Food and Drug Administration approved the country’s first interoperable insulin pump Feb. 14, reporting the technology will help diabetics better individualize their treatment regimens.

Results from President Donald Trump’s latest physical, released Feb. 14., reveal the president’s overall cholesterol has improved since last year’s check-up, according to the Associated Press. But Trump has also gained weight and is now classified as obese, which could raise his already elevated risk for heart disease.

A 73-year-old Florida man posing as a fake doctor was arrested after he diagnosed an undercover cop with diabetes and high cholesterol and offered to “cure” the man with a $2,000 autologous blood transfusion, the Miami Herald reported Feb. 13.

“Rather than bringing in many additional statin candidates, this testing should serve as a decision aid to ‘de-risk’ certain patients and distinguish those who may benefit from preventive pharmacologic therapies," Johns Hopkins researchers wrote in the Annals of Internal Medicine.

A capsule no bigger than a blueberry could be the future of insulin delivery for type 1 diabetics, according to researchers at MIT.

UnitedHealthcare partnered with Medtronic Feb. 1 to make the device company’s MiniMed 670G insulin pump system its preferred pump for diabetics aged 7 and up—a move the Juvenile Diabetes Research Foundation (JDRF) calls “an unacceptable step backward” and says effectively limits patients’ choices to one product.

Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

Statin therapy reduces the risk of major cardiovascular events across all age ranges, even among people older than 75, according to a meta-analysis published in The Lancet.